Moreover, lncRNA TUG1 is upregulated in anthracylines resistant AML cells via inhibition of miR-34a and recruitment of EZH2 or RUNXOR is upregulated in t(8;21) AML and after ARA-C treatment [79,80]. This evidence concerns the gene EZH2 and acute myeloid leukemia.